<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the effects of a potent and selective <z:chebi fb="68" ids="48706">antagonist</z:chebi> of alpha-amino-3-hydroxy-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-<z:chebi fb="0" ids="35595">isoxazole</z:chebi> <z:chebi fb="0" ids="30768">propionic acid</z:chebi> (AMPA) subtype of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptor, YM90K, on <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> using a newly developed <z:hpo ids='HP_0001297'>stroke</z:hpo> model of thrombotic distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Male spontaneously hypertensive rats (5-7 months old) were subjected to photochemically-induced distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> as previously described [<z:hpo ids='HP_0001297'>Stroke</z:hpo> 26 (1996) 333-336] </plain></SENT>
<SENT sid="2" pm="."><plain>Intravenous infusion of YM90K (n = 8) (5 mg/kg per h for 1 h) or the same amount of vehicle (n = 8) (alkaline saline) was started 5 min after distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Penumbral cerebral blood flow was determined with laser-Doppler flowmetry </plain></SENT>
<SENT sid="4" pm="."><plain>Three days after the ischemic insult, brains were stained with 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were determined </plain></SENT>
<SENT sid="5" pm="."><plain>One hour infusion of YM90K significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 34% (93 +/- 23 mm3 in control group vs. 61 +/- 25 mm3 in YM90K-treated group, P = 0.017) </plain></SENT>
<SENT sid="6" pm="."><plain>There were no significant differences in the degrees of cerebral blood flow reduction after distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> between the YM90K treated and control groups </plain></SENT>
<SENT sid="7" pm="."><plain>YM90K reduces <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in experimental <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> produced by photothrombotic distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="8" pm="."><plain>The present results demonstrated beneficial effects of AMPA receptor blockade on <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>